During the past decade, Centre for Human Drug Research conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 4 clinical trials were completed, i.e. on average, 7.3% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 2 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre for Human Drug Research" #1 sponsor was "Maruho Co., Ltd." with 10 trials, followed by "Centre for Human Drug Research, Netherlands" with 8 trials sponsored, "Denali Therapeutics Inc." with 4 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 4 trials sponsored and "Pfizer" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre for Human Drug Research" #1 collaborator was "Centre for Human Drug Research, Netherlands" with 3 trials as a collaborator, "Maruho Co., Ltd." with 3 trials as a collaborator, "Leiden University Medical Center" with 2 trials as a collaborator, "Takeda" with 2 trials as a collaborator and "Janssen Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Centre for Human Drug Research" are "Healthy" (11 trials), "Healthy Volunteers" (5 trials), "Cutaneous Warts" (3 trials), "Pain" (3 trials) and "Parkinson's Disease" (3 trials). Many other conditions were trialed in "Centre for Human Drug Research" in a lesser frequency.

Most popular intervention types in "Centre for Human Drug Research" are "Drug" (60 trials), "Other" (10 trials), "Biological" (7 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "ACT-541468" (3 trials), "CLS003" (3 trials), "Omiganan" (3 trials) and "DNL151" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centre for Human Drug Research" are 55 trials for "All" genders, 13 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre for Human Drug Research". undefined are not yet recruiting, 7 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Centre for Human Drug Research, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centre for Human Drug Research, 49 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".